AIDS at a Crossroads
How Antiretrovirals and Community Transformed the HIV Response
Will be published approx. on 30. July 2026
Book
Paperback/Softback
336 pages
978-0-19-883701-5 (ISBN)
Description
AIDS at a Crossroads: How Antiretrovirals and Community Transformed the HIV Response chronicles the global HIV response through 2023, and the remarkable progress achieved toward epidemic control through innovation in biomedicine, the resolve of political leadership, and the steadfast commitment of communities on the frontlines of the HIV response. In this sequel to A Decade of HAART: The Development and Global Impact of Highly Active Antiretroviral Therapy (2008), leading voices in HIV medicine and global health chronicle how innovation in biomedicine, political will, and community leadership together transformed the trajectory of the HIV pandemic.
This timely volume captures the extraordinary progress toward epidemic control achieved through antiretroviral therapy, pre-exposure prophylaxis, and the validation of treatment as prevention, while candidly assessing the stigma, inequities, and policy failures that persist. Written during the COVID-19 pandemic, the book includes initial insights into the colliding pandemic's shock on health systems and how this novel public health threat tested the resilience of HIV responses everywhere. New political and fiscal shocks in 2025 - precipitated by the Trump administration's HIV and global health policy reversals and funding cuts - now threaten this progress in the United States and beyond.
Divided into three sections spanning biomedical innovation, country case studies, and strategies for achieving the goal of ending AIDS as a public health threat, AIDS at a Crossroads offers historical reflection on a public health success yet to be attained and an urgent warning that controlling, eliminating, and ultimately eradicating the HIV pandemic will depend as much on scientific breakthroughs as on sustained political will and community leadership.
This timely volume captures the extraordinary progress toward epidemic control achieved through antiretroviral therapy, pre-exposure prophylaxis, and the validation of treatment as prevention, while candidly assessing the stigma, inequities, and policy failures that persist. Written during the COVID-19 pandemic, the book includes initial insights into the colliding pandemic's shock on health systems and how this novel public health threat tested the resilience of HIV responses everywhere. New political and fiscal shocks in 2025 - precipitated by the Trump administration's HIV and global health policy reversals and funding cuts - now threaten this progress in the United States and beyond.
Divided into three sections spanning biomedical innovation, country case studies, and strategies for achieving the goal of ending AIDS as a public health threat, AIDS at a Crossroads offers historical reflection on a public health success yet to be attained and an urgent warning that controlling, eliminating, and ultimately eradicating the HIV pandemic will depend as much on scientific breakthroughs as on sustained political will and community leadership.
More details
Language
English
Place of publication
Oxford
United Kingdom
Target group
College/higher education
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 246 mm
Width: 171 mm
ISBN-13
978-0-19-883701-5 (9780198837015)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Dr. Jose M. Zuniga is President/CEO of the International Association of Providers of AIDS Care (IAPAC), Fast-Track Cities Institute, and Fast-Track Health. He is the former Chair of the Joint United Nations Programme on HIV/AIDS (UNAIDS) Task Force on Urban Health, and the Lancet-HIV Commission on the Future of Urban HIV Responses. He is Editor Emeritus of the Journal of the International Association of Providers of AIDS Care and serves on the Editorial Advisory Board of the International Journal of HIV/AIDS Prevention, Education, and Behavioural Science. Dr. Zuniga routinely advises United Nations health agencies, including the World Health Organization (WHO) and its regional offices, as well as bilateral institutions such as the US President's Emergency Plan for AIDS Relief (PEPFAR). He is a member of the American Public Health Association (USA), the National Hispanic Medical Association (USA), and Senior Associate Member of the Royal Society of Medicine (UK).
Dr. K. Rivet Amico is a Professor in the Department of Health Behavior and Health Equity at the University of Michigan's School of Public Health. She is an active contributor in the areas of HIV prevention and treatment, social-behavioural theory development, intervention implementation, and intervention evaluation and measurement. Her research includes work with engagement in HIV care, pre-exposure prophylaxis (PrEP), and social structural factors influencing health and well-being in communities affected by the HIV epidemic. She uses mixed methods, implementation science, and program development principles in her work to advance the reach and quality of care and prevention services. Dr. Amico has strong interests in research design, implementation science, program evaluation and community capacity sharing with youth, pregnant and breast-feeding women, and LGBTQI+ communities in the United States and sub-Saharan Africa.
Mx. Corey Prachniak is a lawyer who serves as Director of Health Equity at CenterLink, where they direct HealthLink, a program that supports LGBTQI+ community centers worldwide. They have a strong background in LGBTQI+ health and public health advocacy, including in their prior role as Senior Advisor on Public Health at the International Association of Providers of AIDS Care (IAPAC), leading research initiatives on urban HIV epidemics and LGBTQI+ health equity. Mx. Prachniak has also held positions at the Commonwealth of Massachusetts, Harvard University, Deloitte Consulting LLP, and other organizations, contributing to research and advocacy efforts in the fields of healthcare technology, human rights, and reproductive rights. They were admitted to the bar in the State of Maryland in 2013 and the Commonwealth of Massachusetts in 2015.
Dr. K. Rivet Amico is a Professor in the Department of Health Behavior and Health Equity at the University of Michigan's School of Public Health. She is an active contributor in the areas of HIV prevention and treatment, social-behavioural theory development, intervention implementation, and intervention evaluation and measurement. Her research includes work with engagement in HIV care, pre-exposure prophylaxis (PrEP), and social structural factors influencing health and well-being in communities affected by the HIV epidemic. She uses mixed methods, implementation science, and program development principles in her work to advance the reach and quality of care and prevention services. Dr. Amico has strong interests in research design, implementation science, program evaluation and community capacity sharing with youth, pregnant and breast-feeding women, and LGBTQI+ communities in the United States and sub-Saharan Africa.
Mx. Corey Prachniak is a lawyer who serves as Director of Health Equity at CenterLink, where they direct HealthLink, a program that supports LGBTQI+ community centers worldwide. They have a strong background in LGBTQI+ health and public health advocacy, including in their prior role as Senior Advisor on Public Health at the International Association of Providers of AIDS Care (IAPAC), leading research initiatives on urban HIV epidemics and LGBTQI+ health equity. Mx. Prachniak has also held positions at the Commonwealth of Massachusetts, Harvard University, Deloitte Consulting LLP, and other organizations, contributing to research and advocacy efforts in the fields of healthcare technology, human rights, and reproductive rights. They were admitted to the bar in the State of Maryland in 2013 and the Commonwealth of Massachusetts in 2015.
Editor
President/CEO, International Association of Providers of AIDS Care (IAPAC), President/CEO, Fast-Track Cities Institute, and Fast-Track Health, Washington, DC, USA
Professor, Department of Health Behavior and Health Equity, School of Public Health, University of Michigan, Ann Arbor, MI, USA
Former Senior Advisor on Public Health, International Association of Providers of AIDS Care (IAPAC), Washington, DC, USA
Content
Part 1. ART, PrEP, and the Continuum from Despair to a Decade of Action Chapter 1: Jose M. Zuniga: How Antiretroviral Therapy Turned the Tide of the HIV Pandemic Chapter 2: Myron S. Cohen, Theresa R. Gamble, and Marybeth McCauley: HPTN 052, the PARTNER Study, and the Dawn of Treatment as Prevention Chapter 3: Lee Fairlie, Faeezah Patel, and James McIntyre: The Impact of Option B+ PMTCT Implementation on Mothers Living with HIV Chapter 4: Christopher Duncombe: Challenges and Successes from a Decade and a Half of HIV Antiretroviral Therapy Chapter 5: Lao-Tzu Allan-Blitz and Kenneth H. Mayer: Pre-Exposure Prophylaxis for the Biomedical Prevention of HIV Infection Chapter 6: McLaughlin Angela, Julio S. G Montaner, and Jeffrey B Joy: Molecular Genetics: Using Phylogenetics to Enhance the HIV Response Chapter 7: Caroline Passaes and Asier Saez-Cirion: From Elimination to Eradication: The Role of an HIV Vaccine and/or Cure Part 2. Action to Impact: Country Experiences with ART and PrEP Scale-Up Chapter 8: Irene Mukui, Francesca Odhiambo, Maurice Aluda, and Elizabeth Anne Bukusi: Country Review: Kenya Chapter 9: Yogan Pillay: Country Review: South Africa Chapter 10: Andrew D. Kambugu and Elly Tebasoboke Katabira: Country Review: Uganda Chapter 11: Jillian S. Y Lau, David W. J. Griffin, Mihiri P. Weerasuria, James H. McMahon, and Jennifer F. Hoy: Country Review: Australia Chapter 12: Zunyou Wu, Yan Zhao, and Jennifer M. McGoogan: Country Review: China Chapter 13: Praphan Phanuphak and Nittaya Phanuphak: Country Review: Thailand Chapter 14: Ana Roberta Pati Pascom, Nazle Mendonca Collaco Veras, Grace Perpetuo, Eduardo Malheiros, Gerson Fernando Pereira, and Adele S. Benzaken: Country Review: Brazil Chapter 15: J. Deas Van Onacker, E. G. Robin, K. Francois, V. Rouzier, N. Segaren, D. Jean Francois, M. M. Zevallos, S. Laguerre, N. Lamothe, F. Moise, M. M. Deschamps, B Liautaud, , J. W. Pape, P. Cremieux, F. Leandre, and S. Koenig: Country Review: Haiti Chapter 16: Leandro Cahn and Pedro Cahn: Country Review: Argentina Chapter 17: Taraz Samandari, Stacy Cohen, Kristen L. Hess, Steven R. Young, Janet Cleveland, Antigone Dempsey, and David W. Purcell: Country Review: United States Chapter 18: Peter Reiss: Country Review: The Netherlands Chapter 19: Matilde Sanchez-Conde, Maria J. Vivancos-Gallego, Javier Martinez-Sanz, and Santiago Moreno: Country Review: Spain Part 3. Challenges and Opportunities for Ending AIDS as a Public Health Threat Chapter 20: Matthew Weait: A Revitalized Human Rights and Legal Framework for Ending AIDS Chapter 21: Alan Whiteside: Financing the AIDS Response: Bilateral, Multilateral, and National Investments Chapter 22: Artur Acelino Francisco Luz Nunes Queiroz, Ricardo Baptista Leite, and Amish Laxmidas: Political Leadership for HIV Control: It Is Time to Unite for Action Chapter 23: Jose M. Zuniga, Sindhu Ravishankar, and Christopher Duncombe: Urbanizing Global Goals by Accelerating HIV Responses in Fast-Track Cities Chapter 24: Helena Nygren-Krug: Leveraging the HIV Response for the Achievement of Universal Health Coverage Chapter 25: Jose M. Zuniga: Conclusion